CNSPNasdaqPharmaceutical PreparationsFiscal year ends December 31
CNS Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$4.99+0.14 (+2.87%)
Close on Oct 19, 2026
- Market cap
- $34.12M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
19.2%
0M of 1M shares
Institutional holders
11
4 new, 4 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
2 buys · 0 sales
Net bought $44.01K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Cortice Biosciences, Inc. | 573,368 | 5.70% | 13D (active) | Jul 29, 2024 |
| Steven Boyd | 561,148 | 9.99% | 13G (passive) | Jun 30, 2025 |
| Stonepine Capital Management, LLC | 48,827 | 7.90% | 13G (passive) amendment | Dec 31, 2025 |
| Jon M. Plexico | 159,790 | 9.90% | 13G (passive) amendment | Mar 31, 2026 |
| Neil Shahrestani | 147,290 | 9.90% | 13G (passive) amendment | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CNSP | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Ikarian Capital, LLC | 135,830 | 9.29% | $649.27K | +90,000 | 0.07% |
| ADAR1 Capital Management, LLC | 70,000 | 4.79% | $334.60K | New | 0.02% |
| Stonepine Capital Management, LLC | 41,573 | 2.84% | $198.72K | −19,427 | 0.11% |
| Boothbay Fund Management, LLC | 13,524 | 0.93% | $64.65K | – | 0.00% |
| Vanguard Fiduciary Trust Co | 10,226 | 0.70% | $48.88K | New | 0.00% |
| Vanguard Capital Management LLC | 6,993 | 0.48% | $33.43K | New | 0.00% |
| UBS Group AG | 1,461 | 0.10% | $6.98K | +732 | 0.00% |
| Tower Research Capital LLC (TRC) | 799 | 0.05% | $3.82K | −511 | 0.00% |
| Barclays PLC | 19 | 0.00% | $91 | New | 0.00% |
| Barrett & Company, Inc. | 8 | 0.00% | $38 | – | 0.00% |
| Danske Bank A/S | 1 | 0.00% | $5 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 11 | 0M | 19.2% | 4 / 2 | 2 / 4 | 0M | 0M |
| Q1 2026 | 11 | 0M | 10.0% | 4 / 2 | 0 / 2 | 0M | 0M |
| Q4 2025 | 9 | 0M | 8.5% | 3 / 1 | 1 / 2 | 0M | 0M |
| Q3 2025 | 8 | 0M | 1.7% | 8 / 0 | 0 / 1 | 0M | 0M |
| Q2 2025 | 1 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of CNSP | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 6,993 | 0.48% | $33.43K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 6,736 | 0.46% | $36.64K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 555 | 0.04% | $3.02K | 0.00% | May 31, 2026 |
| Blackstone Alternative Multi-Strategy Fund | -49 | -0.00% | -$234 | -0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| John M. Climaco | Chief Executive Officer, Director | 215,676 | 14.76% | Nov 19, 2025 |
| Rami Levin | CEO and President | 4,750 | 0.33% | Aug 18, 2026 |
| Eric Faulkner | Chief Technology Officer | – | – | Mar 4, 2026 |
| Steve O'Loughlin | Chief Financial Officer | – | – | Mar 4, 2026 |
| Christopher Downs | Chief Financial Officer | 103,438 | 7.08% | Nov 19, 2025 |
| Michal Fisher | Director | 2,000 | 0.14% | Aug 18, 2026 |
| Faith L. Charles | Director | 7,100 | 0.49% | May 20, 2026 |
| Jeffry R. Keyes | Director | 11,100 | 0.76% | Nov 19, 2025 |
| Bettina M. Cockroft | Director | – | – | Nov 19, 2025 |
| Amy Mahery | Director | – | – | Nov 19, 2025 |
| Jerzy Gumulka | Director | 43,006 | 2.94% | Nov 19, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Rami Levin CEO and President | Aug 14, 2026 | Option exercise | −4,750 | – | – | 4,750 |
| Michal Fisher Director | May 18, 2026 | Buy | +2,000 | $5.00 | $10.00K | 2,000 |
| Faith L. Charles Director | May 18, 2026 | Buy | +7,100 | $4.79 | $34.01K | 7,100 |
| Carl Anthony Evans Director | Feb 1, 2024 | Buy | +33,333 | $0.30 | $10.00K | 33,458 |
| Christopher Downs Chief Financial Officer | Feb 1, 2024 | Buy | +66,666 | $0.30 | $20.00K | 103,438 |
| Jerzy Gumulka Director | Feb 1, 2024 | Buy | +33,333 | $0.30 | $10.00K | 43,006 |
| John M. Climaco Chief Executive Officer, Director | Feb 1, 2024 | Buy | +166,666 | $0.30 | $50.00K | 215,676 |
| Christopher Downs Chief Financial Officer | Aug 22, 2023 | Buy | +27,000 | $1.27 | $34.29K | 36,772 |
| John M. Climaco Chief Executive Officer, Director | Aug 16, 2023 | Buy | +2,750 | $1.80 | $4.95K | 49,010 |
| Christopher Downs Chief Financial Officer | Apr 28, 2023 | Option exercise | +521 | – | – | 9,772 |
| John M. Climaco Chief Executive Officer, Director | Apr 28, 2023 | Option exercise | +1,250 | – | – | 46,260 |
| Jerzy Gumulka Director | Apr 19, 2023 | Buy | +2,500 | $1.70 | $4.25K | 9,673 |
| Christopher Downs Chief Financial Officer | Apr 17, 2023 | Buy | +3,100 | $3.20 | $9.92K | 9,251 |
| John M. Climaco Chief Executive Officer, Director | Apr 12, 2023 | Buy | +15,000 | $0.69 | $10.35K | 45,010 |
| Jerzy Gumulka Director | Apr 10, 2023 | Buy | +7,173 | $0.74 | $5.31K | 7,173 |
| Waldemar Priebe 10% owner | Mar 28, 2023 | Sale(10b5-1 plan) | −10,000 | $1.04 | $10.40K | 156,807 |
| Waldemar Priebe 10% owner | Mar 27, 2023 | Sale(10b5-1 plan) | −5,000 | $1.09 | $5.45K | 166,807 |
| Waldemar Priebe 10% owner | Mar 24, 2023 | Sale(10b5-1 plan) | −5,000 | $1.08 | $5.40K | 171,807 |
| Waldemar Priebe 10% owner | Mar 23, 2023 | Sale(10b5-1 plan) | −10,000 | $1.08 | $10.80K | 176,807 |
| Waldemar Priebe 10% owner | Mar 22, 2023 | Sale(10b5-1 plan) | −5,000 | $1.08 | $5.40K | 186,807 |
| Waldemar Priebe 10% owner | Mar 21, 2023 | Sale(10b5-1 plan) | −5,000 | $1.10 | $5.50K | 191,807 |
| Waldemar Priebe 10% owner | Mar 20, 2023 | Sale(10b5-1 plan) | −5,000 | $1.08 | $5.40K | 196,807 |
| Waldemar Priebe 10% owner | Mar 17, 2023 | Sale(10b5-1 plan) | −5,000 | $1.13 | $5.65K | 201,807 |
| Waldemar Priebe 10% owner | Mar 16, 2023 | Sale(10b5-1 plan) | −5,000 | $1.24 | $6.20K | 206,807 |
| Waldemar Priebe 10% owner | Mar 15, 2023 | Sale(10b5-1 plan) | −5,000 | $1.22 | $6.10K | 211,807 |
| Waldemar Priebe 10% owner | Mar 14, 2023 | Sale(10b5-1 plan) | −5,000 | $1.35 | $6.75K | 216,807 |
| Waldemar Priebe 10% owner | Mar 13, 2023 | Sale(10b5-1 plan) | −5,000 | $1.30 | $6.50K | 221,807 |
| Waldemar Priebe 10% owner | Mar 10, 2023 | Sale(10b5-1 plan) | −5,000 | $1.29 | $6.45K | 226,807 |
| Waldemar Priebe 10% owner | Dec 9, 2022 | Sale(10b5-1 plan) | −2,798 | $2.43 | $6.80K | 231,807 |
| Waldemar Priebe 10% owner | Dec 8, 2022 | Sale(10b5-1 plan) | −5,500 | $2.40 | $13.20K | 234,605 |
| Waldemar Priebe 10% owner | Dec 7, 2022 | Sale(10b5-1 plan) | −5,500 | $2.46 | $13.53K | 240,105 |
| Waldemar Priebe 10% owner | Dec 6, 2022 | Sale(10b5-1 plan) | −5,500 | $2.47 | $13.59K | 245,605 |
| Christopher Downs Chief Financial Officer | Mar 11, 2022 | Award | +33,000 | $0.31 | $10.23K | 184,500 |
| Carl Anthony Evans Director | Mar 8, 2022 | Award | +3,750 | $0.27 | $1.01K | 3,750 |
| Jeffry R. Keyes Director | Mar 7, 2022 | Award | +11,100 | $0.30 | $3.33K | 11,100 |
| John M. Climaco Chief Executive Officer, Director | Mar 7, 2022 | Award | +35,000 | $0.28 | $9.80K | 940,298 |
| Christopher Downs Chief Financial Officer | Dec 6, 2021 | Buy | +5,000 | $0.94 | $4.70K | 151,500 |
| Christopher Downs Chief Financial Officer | Nov 19, 2021 | Buy | +4,500 | $1.15 | $5.18K | 146,500 |
| John M. Climaco Chief Executive Officer, Director | Nov 16, 2021 | Award | +5,000 | $1.28 | $6.40K | 905,298 |
| Christopher Downs Chief Financial Officer | Aug 24, 2020 | Buy | +142,000 | $2.04 | $289.68K | 142,000 |
| Waldemar Priebe 10% owner | May 5, 2020 | Other | −1,495,867 | – | – | 7,533,133 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.